Abstract
Background: ADAR proteins are among the most extensively studied RNA binding proteins. They bind to their target and deaminate specific adenosines to inosines. ADAR activity is essential, and the editing of a subset of their targets is critical for viability. Recently, a huge number of novel ADAR targets were detected by analyzing next generation sequencing data. Most of these novel editing sites are located in lineage-specific genomic repeats, probably a result of overactivity of editing enzymes, thus masking the functional sites. In this study we aim to identify the set of mammalian conserved ADAR targets.Results: We used RNA sequencing data from human, mouse, rat, cow, opossum, and platypus to define the conserved mammalian set of ADAR targets. We found that the conserved mammalian editing sites are surprisingly small in number and have unique characteristics that distinguish them from non-conserved ones. The sites that constitute the set have a distinct genomic distribution, tend to be located in genes encoding neurotransmitter receptors or other synapse related proteins, and have higher editing and expression levels. We also found a high consistency of editing levels of this set within mice strains and between human and mouse. Tight regulation of editing in these sites across strains and species implies their functional importance.Conclusions: Despite the discovery of numerous editing targets, only a small number of them are conserved within mammalian evolution. These sites are extremely highly conserved and exhibit unique features, such as tight regulation, and probably play a pivotal role in mammalian biology.
Original language | English |
---|---|
Article number | R5 |
Journal | Genome Biology |
Volume | 15 |
Issue number | 1 |
DOIs | |
State | Published - 7 Jan 2014 |
Bibliographical note
Funding Information:We thank Jin Billy Li for comments on the manuscript, Yarden Opatowsky for helpful discussion, Lily Bazak and Miri Danan for help in data analysis, Orshay Gabay for graphical help and useful comments, Sol Efroni and Lior Appelbaum for data sharing and Shoshana Naiman for discussion. This work was supported by the European Research Council [311257] and by the Legacy Heritage Biomedical Science Partnership, Israel Science Foundation (grant numbers 1466/10), and by the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant No 41/11).
Funding
We thank Jin Billy Li for comments on the manuscript, Yarden Opatowsky for helpful discussion, Lily Bazak and Miri Danan for help in data analysis, Orshay Gabay for graphical help and useful comments, Sol Efroni and Lior Appelbaum for data sharing and Shoshana Naiman for discussion. This work was supported by the European Research Council [311257] and by the Legacy Heritage Biomedical Science Partnership, Israel Science Foundation (grant numbers 1466/10), and by the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant No 41/11).
Funders | Funder number |
---|---|
Legacy Heritage Biomedical Science Partnership, Israel Science Foundation | 1466/10 |
Seventh Framework Programme | 311257, 242763 |
European Commission | |
Israel Science Foundation | 41/11 |
Planning and Budgeting Committee of the Council for Higher Education of Israel |